James Liu1, Ella Gibson1, Shawn Ramchal1, Vikram Shankar1, Kisha Piggott1, Yevgeniy Sychev1, Albert S Li2, Prabakar K Rao1, Todd P Margolis1, Emily Fondahn3, Malavika Bhaskaranand4, Kaushal Solanki4, Rithwick Rajagopal5. 1. Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri. 2. Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, Maryland. 3. Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. 4. Eyenuk, Inc, Woodland Hills, California. 5. Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri. Electronic address: rajagopalr@wustl.edu.
Abstract
PURPOSE: Retinal screening examinations can prevent vision loss resulting from diabetes but are costly and highly underused. We hypothesized that artificial intelligence-assisted nonmydriatic point-of-care screening administered during primary care visits would increase the adherence to recommendations for follow-up eye care in patients with diabetes. DESIGN: Prospective cohort study. PARTICIPANTS: Adults 18 years of age or older with a clinical diagnosis of diabetes being cared for in a metropolitan primary care practice for low-income patients. METHODS: All participants underwent nonmydriatic fundus photography followed by automated retinal image analysis with human supervision. Patients with positive or inconclusive screening results were referred for comprehensive ophthalmic evaluation. Adherence to referral recommendations was recorded and compared with the historical adherence rate from the same clinic. MAIN OUTCOME MEASURE: Rate of adherence to eye screening recommendations. RESULTS: By automated screening, 8.3% of the 180 study participants had referable diabetic eye disease, 13.3% had vision-threatening disease, and 29.4% showed inconclusive results. The remaining 48.9% showed negative screening results, confirmed by human overread, and were not referred for follow-up ophthalmic evaluation. Overall, the automated platform showed a sensitivity of 100% (confidence interval, 92.3%-100%) in detecting an abnormal screening results, whereas its specificity was 65.7% (confidence interval, 57.0%-73.7%). Among patients referred for follow-up ophthalmic evaluation, the adherence rate was 55.4% at 1 year compared with the historical adherence rate of 18.7% (P < 0.0001, Fisher exact test). CONCLUSIONS: Implementation of an automated diabetic retinopathy screening system in a primary care clinic serving a low-income metropolitan patient population improved adherence to follow-up eye care recommendations while reducing referrals for patients with low-risk features.
PURPOSE: Retinal screening examinations can prevent vision loss resulting from diabetes but are costly and highly underused. We hypothesized that artificial intelligence-assisted nonmydriatic point-of-care screening administered during primary care visits would increase the adherence to recommendations for follow-up eye care in patients with diabetes. DESIGN: Prospective cohort study. PARTICIPANTS: Adults 18 years of age or older with a clinical diagnosis of diabetes being cared for in a metropolitan primary care practice for low-income patients. METHODS: All participants underwent nonmydriatic fundus photography followed by automated retinal image analysis with human supervision. Patients with positive or inconclusive screening results were referred for comprehensive ophthalmic evaluation. Adherence to referral recommendations was recorded and compared with the historical adherence rate from the same clinic. MAIN OUTCOME MEASURE: Rate of adherence to eye screening recommendations. RESULTS: By automated screening, 8.3% of the 180 study participants had referable diabetic eye disease, 13.3% had vision-threatening disease, and 29.4% showed inconclusive results. The remaining 48.9% showed negative screening results, confirmed by human overread, and were not referred for follow-up ophthalmic evaluation. Overall, the automated platform showed a sensitivity of 100% (confidence interval, 92.3%-100%) in detecting an abnormal screening results, whereas its specificity was 65.7% (confidence interval, 57.0%-73.7%). Among patients referred for follow-up ophthalmic evaluation, the adherence rate was 55.4% at 1 year compared with the historical adherence rate of 18.7% (P < 0.0001, Fisher exact test). CONCLUSIONS: Implementation of an automated diabetic retinopathy screening system in a primary care clinic serving a low-income metropolitan patient population improved adherence to follow-up eye care recommendations while reducing referrals for patients with low-risk features.
Authors: Manuel E Gegundez-Arias; Diego Marin; Beatriz Ponte; Fatima Alvarez; Javier Garrido; Carlos Ortega; Manuel J Vasallo; Jose M Bravo Journal: Comput Biol Med Date: 2017-07-08 Impact factor: 4.589
Authors: Jessica Kuo; James C Liu; Ella Gibson; P Kumar Rao; Todd P Margolis; Bradley Wilson; Mae O Gordon; Emily Fondahn; Rithwick Rajagopal Journal: Mo Med Date: 2020 May-Jun
Authors: Sophia Y Wang; Chris A Andrews; Thomas W Gardner; Michael Wood; Kanakadurga Singer; Joshua D Stein Journal: JAMA Ophthalmol Date: 2017-05-01 Impact factor: 7.389
Authors: C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer Journal: Ophthalmology Date: 2003-09 Impact factor: 12.079
Authors: Chiu-Fang Chou; Cheryl E Sherrod; Xinzhi Zhang; Lawrence E Barker; Kai McKeever Bullard; John E Crews; Jinan B Saaddine Journal: Diabetes Care Date: 2013-09-05 Impact factor: 19.112
Authors: Dawn A Sim; Danny Mitry; Philip Alexander; Adam Mapani; Srini Goverdhan; Tariq Aslam; Adnan Tufail; Catherine A Egan; Pearse A Keane Journal: J Diabetes Sci Technol Date: 2016-02-01
Authors: Spencer D Fuller; Jenny Hu; James C Liu; Ella Gibson; Martin Gregory; Jessica Kuo; Rithwick Rajagopal Journal: J Diabetes Sci Technol Date: 2020-10-30
Authors: Sharon M Hudson; Bobeck S Modjtahedi; Danielle Altman; Jennifer J Jimenez; Tiffany Q Luong; Donald S Fong Journal: Clin Ophthalmol Date: 2022-04-04